Avadel Pharmaceuticals Files 8-K on Financials
| Field | Detail |
|---|---|
| Company | Avadel Pharmaceuticals PLC |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: AVDL
TL;DR
AVDL filed an 8-K on May 7th detailing financial results and exhibits.
AI Summary
Avadel Pharmaceuticals plc filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. Avadel Pharmaceuticals plc is incorporated in Ireland and its principal executive offices are located in Dublin.
Why It Matters
This filing provides investors with an update on Avadel Pharmaceuticals' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- AVADEL PHARMACEUTICALS PLC (company) — Registrant
- May 7, 2025 (date) — Date of Report
- Ireland (location) — Jurisdiction of Incorporation
- Dublin (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Avadel Pharmaceuticals plc's results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on May 7, 2025.
Where is Avadel Pharmaceuticals plc incorporated?
Avadel Pharmaceuticals plc is incorporated in Ireland.
What are the principal executive offices of Avadel Pharmaceuticals plc?
The principal executive offices of Avadel Pharmaceuticals plc are located at 10 Earlsfort Terrace, Dublin 2, Ireland.
What is the Commission File Number for Avadel Pharmaceuticals plc?
The Commission File Number for Avadel Pharmaceuticals plc is 001-37977.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding AVADEL PHARMACEUTICALS PLC.